secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearwater Analytics Holdings, Inc. (CWAN)
CIK:        0001866368
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001628280-25-006359
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearwater Q4 revenue $126.5M (+27.7% YoY); guides FY2025 rev $535.5-542M; $1.5B Enfusion deal noted
--------------------------------------------------------------------------------

- Q4 revenue $126.5M (+27.7% YoY); ARR $474.9M (+25.3% YoY); net income $420.3M includes $472M one-time tax benefit from DTA release.
- Q4 Adj EBITDA $41.7M (+39% YoY), margin 33.0% (+270 bps); FY2024 Adj EBITDA $145.7M, margin 32.2%.
- Net revenue retention rate 116% (vs 107% a year ago); clients 1,462, including 100 with >$1M ARR.
- Guidance: Q1 2025 rev ~$125M, Adj EBITDA ~$41.5M; FY2025 rev $535.5-542M (19-20% growth), Adj EBITDA $182-185M (~34% margin).
- Recent highlight: announced $1.5B acquisition of Enfusion on Jan 13, 2025, to create front-to-back investment management platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1866368/000162828025006359/0001628280-25-006359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1866368/000162828025006359/cwan-20250219.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-006359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer